Seroreactivity against MAGE-A and LAGE-1 proteins in melanoma patients
Background: Cancer-testis antigens exemplify a growing number of tumour antigens which are expressed in a variety of malignancies, but not in normal tissues other than germ cells, primarily those of the testis. Objectives: To investigate the humoral response to known cancer-testis antigens in melano...
Saved in:
| Main Authors: | , , , |
|---|---|
| Format: | Article (Journal) |
| Language: | English |
| Published: |
22 August 2003
|
| In: |
British journal of dermatology
Year: 2003, Volume: 149, Issue: 2, Pages: 282-288 |
| ISSN: | 1365-2133 |
| DOI: | https://doi.org/10.1046/j.1365-2133.2003.05410.x |
| Online Access: | Verlag, lizenzpflichtig, Volltext: https://doi.org/https://doi.org/10.1046/j.1365-2133.2003.05410.x Verlag, lizenzpflichtig, Volltext: https://onlinelibrary.wiley.com/doi/abs/10.1046/j.1365-2133.2003.05410.x 
|
| Author Notes: | D. Usener, A. Gerhardt, D. Schadendorf and S. Eichmüller |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1740404998 | ||
| 003 | DE-627 | ||
| 005 | 20230320133728.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 201123s2003 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1046/j.1365-2133.2003.05410.x |2 doi | |
| 035 | |a (DE-627)1740404998 | ||
| 035 | |a (DE-599)KXP1740404998 | ||
| 035 | |a (OCoLC)1341377885 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Usener, Dirk |d 1972- |e VerfasserIn |0 (DE-588)124823378 |0 (DE-627)366751735 |0 (DE-576)294520791 |4 aut | |
| 245 | 1 | 0 | |a Seroreactivity against MAGE-A and LAGE-1 proteins in melanoma patients |c D. Usener, A. Gerhardt, D. Schadendorf and S. Eichmüller |
| 246 | 3 | 0 | |a one |
| 264 | 1 | |c 22 August 2003 | |
| 300 | |a 7 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 23.11.2020 | ||
| 520 | |a Background: Cancer-testis antigens exemplify a growing number of tumour antigens which are expressed in a variety of malignancies, but not in normal tissues other than germ cells, primarily those of the testis. Objectives: To investigate the humoral response to known cancer-testis antigens in melanoma patients. Methods We used phage clones coding for seven different melanoma antigens MAGE-A or LAGE-1A proteins. These clones were isolated using the newly developed DNA hybridization analysis of recombinantly expressed cDNA libraries (HYREX) approach. HYREX combines the advantage of a nonradioactive library screening method with the possibility of subsequently analysing the serological response to the recombinant proteins. We isolated clones coding for MAGE-A1, -A3, -A4b, -A6, -A9 and -A12, as well as LAGE-1A. Additionally, we correlated gene expression and seroreactivity. Results: Between 13% and 27% of sera (n = 15) were reactive against individual tumour antigens. We found the presence of specific antibodies was, with only two exceptions, generally correlated with mRNA expression of the antigen within cell lines derived from the same patient. While cross-reactivity of patients' IgG might play a role in these cases, antibodies from patients' sera were able to distinguish even the closely related MAGE-A3 and -A6. In general, the mRNA expression frequency was higher than the detected IgG responses. Conclusions: Antibody recognition of specific tumour antigens by patients' sera may be used for evaluating the possible immunogenicity of new antigens; serological tests could be used for tumour monitoring purposes. | ||
| 650 | 4 | |a cancer-testis antigens | |
| 650 | 4 | |a DNA screening | |
| 650 | 4 | |a humoral response | |
| 650 | 4 | |a HYREX | |
| 650 | 4 | |a SEREX | |
| 700 | 1 | |a Gerhardt, A. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Schadendorf, Dirk |d 1960- |e VerfasserIn |0 (DE-588)11142576X |0 (DE-627)499566076 |0 (DE-576)289702275 |4 aut | |
| 700 | 1 | |a Eichmüller, Stefan B. |d 1960- |e VerfasserIn |0 (DE-588)1025289226 |0 (DE-627)721986951 |0 (DE-576)37016704X |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t British journal of dermatology |d Oxford : Oxford University Press, 1951 |g 149(2003), 2, Seite 282-288 |h Online-Ressource |w (DE-627)320433803 |w (DE-600)2004086-6 |w (DE-576)091140285 |x 1365-2133 |7 nnas |a Seroreactivity against MAGE-A and LAGE-1 proteins in melanoma patients |
| 773 | 1 | 8 | |g volume:149 |g year:2003 |g number:2 |g pages:282-288 |g extent:7 |a Seroreactivity against MAGE-A and LAGE-1 proteins in melanoma patients |
| 856 | 4 | 0 | |u https://doi.org/https://doi.org/10.1046/j.1365-2133.2003.05410.x |x Verlag |x Resolving-System |z lizenzpflichtig |3 Volltext |
| 856 | 4 | 0 | |u https://onlinelibrary.wiley.com/doi/abs/10.1046/j.1365-2133.2003.05410.x |x Verlag |z lizenzpflichtig |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20201123 | ||
| 993 | |a Article | ||
| 994 | |a 2003 | ||
| 998 | |g 1025289226 |a Eichmüller, Stefan B. |m 1025289226:Eichmüller, Stefan B. |p 4 |y j | ||
| 998 | |g 11142576X |a Schadendorf, Dirk |m 11142576X:Schadendorf, Dirk |d 50000 |e 50000PS11142576X |k 0/50000/ |p 3 | ||
| 999 | |a KXP-PPN1740404998 |e 3810509620 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"note":["Gesehen am 23.11.2020"],"type":{"media":"Online-Ressource","bibl":"article-journal"},"origin":[{"dateIssuedKey":"2003","dateIssuedDisp":"22 August 2003"}],"title":[{"title_sort":"Seroreactivity against MAGE-A and LAGE-1 proteins in melanoma patients","title":"Seroreactivity against MAGE-A and LAGE-1 proteins in melanoma patients"}],"language":["eng"],"person":[{"family":"Usener","display":"Usener, Dirk","given":"Dirk","role":"aut"},{"family":"Gerhardt","display":"Gerhardt, A.","given":"A.","role":"aut"},{"display":"Schadendorf, Dirk","family":"Schadendorf","given":"Dirk","role":"aut"},{"role":"aut","given":"Stefan B.","family":"Eichmüller","display":"Eichmüller, Stefan B."}],"relHost":[{"id":{"doi":["10.1111/(ISSN)1365-2133"],"zdb":["2004086-6"],"eki":["320433803"],"issn":["1365-2133"]},"pubHistory":["Volume 63, issue 1 (January 1951)-"],"recId":"320433803","physDesc":[{"extent":"Online-Ressource"}],"language":["eng"],"origin":[{"publisherPlace":"Oxford ; Oxford [u.a.] ; Oxford [u.a.] ; Oxford","dateIssuedDisp":"1951-","dateIssuedKey":"1951","publisher":"Oxford University Press ; Blackwell Science ; Blackwell ; Wiley-Blackwell"}],"note":["Gesehen am 03.07.25"],"type":{"media":"Online-Ressource","bibl":"periodical"},"titleAlt":[{"title":"BJD"}],"title":[{"title":"British journal of dermatology","title_sort":"British journal of dermatology","subtitle":"BJD ; the journal of the British Association of Dermatologists"}],"part":{"issue":"2","text":"149(2003), 2, Seite 282-288","pages":"282-288","year":"2003","volume":"149","extent":"7"},"corporate":[{"role":"isb","display":"British Association of Dermatologists"}],"disp":"Seroreactivity against MAGE-A and LAGE-1 proteins in melanoma patientsBritish journal of dermatology"}],"id":{"doi":["10.1046/j.1365-2133.2003.05410.x"],"eki":["1740404998"]},"name":{"displayForm":["D. Usener, A. Gerhardt, D. Schadendorf and S. Eichmüller"]},"physDesc":[{"extent":"7 S."}],"recId":"1740404998"} | ||
| SRT | |a USENERDIRKSEROREACTI2220 | ||